Skip to main content
Signal8

Tsuchimoto Kim R

SEC insider (Form 3/4/5 filer). CIK 0001333516. Director at Monopar Therapeutics (MNPR). 12 reported Form 4/5 transactions since Sep 2024; latest on Aug 26, 2026. Located in WILMETTE, IL.

Companies Tsuchimoto Kim R has filed insider reports for

  • Monopar Therapeutics (MNPR): Director
Tsuchimoto Kim R profile photo

Tsuchimoto Kim R

CIK: 0001333516

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (58.3%)

Position reduction

Option Exercises (M)2 (16.7%)

Derivative conversions

Awards (A)2 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (8.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Monopar Therapeutics logo
MNPR

Monopar Therapeutics

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Sale
    Direct
    602 shares at avg. $112.93$68K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Sale
    Direct
    590 shares at avg. $113.84$67K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Exercise
    Direct
    2.1K shares at avg. $30.00$62K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Exercise
    Direct
    2K shares at avg. $14.00$28K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Sale
    Direct
    485 shares at avg. $108.83$53K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Sale
    Direct
    615 shares at avg. $109.56$67K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Sale
    Direct
    700 shares at avg. $110.65$77K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Aug 26, 2026
    Sale
    Direct
    1.1K shares at avg. $111.84$123K
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Dec 2, 2025
    Award

    Stock Options

    Direct
    2.9K shares-
  • Monopar Therapeutics logo
    MNPR

    Monopar Therapeutics

    Jul 14, 2025
    In-the-Money
    Direct
    8.9K shares at avg. $0.01$44.52

1-10 of 12